Drugs / Hyaluronic acid and Ectoin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT05887336 Comparator | Jun 2023 → Aug 2024 | dry eye syndrome | Abilion Medical Systems AB | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hyaluronic acid and Ectoin | “Hyaluronic acid and Ectoin (Hylo Dual Intense)” NCT05887336 ↗ |
| Known as | Hylo Dual Intense | “Hyaluronic acid and Ectoin (Hylo Dual Intense)” NCT05887336 ↗ |